248 results on '"Schmolke, Mirco"'
Search Results
2. A quantitative model for virus uncoating predicts influenza A infectivity
Catalog
Books, media, physical & digital resources
3. Influenza A viruses balance ER stress with host protein synthesis shutoff
4. A clinical protocol for a German birth cohort study of the Maturation of Immunity Against respiratory viral Infections (MIAI).
5. A single respiratory tract infection early in life reroutes healthy microbiome development and affects adult metabolism in a preclinical animal model
6. Influenza A virus infection alters the resistance profile of gut microbiota to clinically relevant antibiotics
7. Ménage à trois: Virus, Host, and Microbiota in Experimental Infection Models
8. Wnt-Independent SARS-CoV-2 Infection in Pulmonary Epithelial Cells
9. Influenza A viruses limit NLRP3‐NEK7‐complex formation and pyroptosis in human macrophages
10. Author Correction: Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection
11. Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection
12. Influenza A virus exploits transferrin receptor recycling to enter host cells
13. Influenza A Virus Genetic Tools: From Clinical Sample to Molecular Clone
14. Silent neonatal influenza A virus infection primes systemic antimicrobial immunity
15. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency
16. Optimizing the Live Attenuated Influenza A Vaccine Backbone for High-Risk Patient Groups
17. The origin of the PB1 segment of swine influenza A virus subtype H1N2 determines viral pathogenicity in mice
18. Inhibition of p38 Mitogen-activated Protein Kinase Impairs Influenza Virus-induced Primary and Secondary Host Gene Responses and Protects Mice from Lethal H5N1 Infection
19. Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target
20. Erk5 Activation Elicits a Vasoprotective Endothelial Phenotype via Induction of Krüppel-like Factor 4 (KLF4)
21. NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets
22. Optimizing the live attenuated influenza A vaccine backbone for high-risk patient groups
23. MEK5/ERK5 Signaling Modulates Endothelial Cell Migration and Focal Contact Turnover
24. INFECTIOUS DISEASE: Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency
25. Cross-presenting [CD103.sup.+] dendritic cells are protected from influenza virus infection
26. Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor
27. Chemokine homeostasis vs. chemokine presentation during severe acute lung injury: the other side of the Duffy antigen receptor for chemokines
28. Visualization of Respiratory Commensal Bacteria in Context of Their Natural Host Environment
29. Respiratory tissue-associated commensal bacteria offer therapeutic potential against pneumococcal colonization
30. Recruitment of p300 by C/EBPβ triggers phosphorylation of p300 and modulates coactivator activity
31. NS deletions convert the 2009-H1N1 pandemic virus into a live attenuated vaccine
32. Author response: Respiratory tissue-associated commensal bacteria offer therapeutic potential against pneumococcal colonization
33. Mode of interaction between the HIV-1-neutralizing monoclonal antibody 2F5 and its epitope
34. Additional file 7: Figure S3. of Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis
35. Additional file 3: Figure S2. of Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis
36. Additional file 9: Figure S4. of Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis
37. High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activity
38. Microbiome disturbance and resilience dynamics of the upper respiratory tract in response to influenza A virus infection in humans and ferrets
39. Overcoming the Neonatal Limitations of Inducing Germinal Centers through Liposome-Based Adjuvants Including C-Type Lectin Agonists Trehalose Dibehenate or Curdlan
40. Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis
41. Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency
42. RIG-I Signaling Is Critical for Efficient Polyfunctional T Cell Responses during Influenza Virus Infection
43. Human Dendritic Cell Response Signatures Distinguish 1918, Pandemic, and Seasonal H1N1 Influenza Viruses
44. Evasion of innate and adaptive immune responses by influenza A virus
45. Evidence for a Novel Mechanism of Influenza Virus-Induced Type I Interferon Expression by a Defective RNA-Encoded Protein
46. The Nucleoprotein of Newly Emerged H7N9 Influenza A Virus Harbors a Unique Motif Conferring Resistance to Antiviral Human MxA
47. Wirkmechanismus und Induktion neutralisierender Antikörper gegen das transmembrane Hüllprotein gp41 von HIV-1
48. A Single Amino Acid Substitution in the Novel H7N9 Influenza A Virus NS1 Protein Increases CPSF30 Binding and Virulence
49. 17β-Estradiol Protects Primary Macrophages Against HIV Infection Through Induction of Interferon-Alpha
50. RIG-I Detects mRNA of Intracellular Salmonella enterica Serovar Typhimurium during Bacterial Infection
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.